8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 10, 2010)

Filed September 10, 2010For Securities:ELV

Summary

Elevance Health, Inc. (ELV), formerly WellPoint, Inc., issued this Form 8-K on September 10, 2010, to disclose that its officers would be meeting with securities analysts and investors from September 13 to September 24, 2010. During these meetings, the company planned to reaffirm its full-year 2010 earnings per share (EPS) guidance, which was initially provided on July 28, 2010. This guidance assumed no significant net investment gains or losses or asset impairment charges beyond those already recorded in the first and second quarters, and was contingent upon the company's ability to secure and maintain adequate premium rates. The filing also included a standard safe harbor statement under the Private Securities Litigation Reform Act of 1995, outlining forward-looking statements and the various risks and uncertainties that could cause actual results to differ from projections. Key risk factors mentioned include increasing government regulation (particularly the impact of the Affordable Care Act), healthcare cost trends, premium rate approvals, competition, enrollment trends, Medicare and Medicaid program risks, and potential impacts from the Express Scripts transaction.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) reaffirms full-year 2010 EPS guidance during analyst and investor meetings.
  • 2The reaffirmed guidance excludes significant net investment gains/losses or asset impairment charges beyond Q1 and Q2 2010.
  • 3Guidance is conditional on the company's ability to secure and maintain sufficient premium rates.
  • 4The report includes forward-looking statements and a detailed safe harbor statement identifying potential risks.
  • 5Key risks mentioned include regulatory changes (Affordable Care Act), healthcare cost trends, and competitive pressures.
  • 6Potential impacts from the Express Scripts transaction are cited as a risk factor.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform investors and analysts that WellPoint, Inc. (now Elevance Health) officers would be participating in meetings between September 13-24, 2010, during which they intended to reaffirm the company's full-year 2010 earnings per share guidance.

WellPoint was reaffirming its full-year 2010 earnings per share (EPS) guidance, which was originally communicated on July 28, 2010. This guidance accounted for specific assumptions regarding investment gains/losses and asset impairments, and was subject to the company's ability to secure adequate premium rates.

The filing highlights several risks, including increased government participation and regulation in health benefits (notably the Affordable Care Act), rising healthcare costs and utilization, the company's ability to secure necessary premium rate approvals, competitive pricing, changes in enrollment mix, risks associated with Medicare and Medicaid programs, and potential disruptions from the recently closed Express Scripts transaction.